Literature DB >> 8712277

Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost.

D L Noah1, M G Smith, J C Gotthardt, J W Krebs, D Green, J E Childs.   

Abstract

OBJECTIVES: This study assessed the rabies exposure and treatment that at least 665 persons in Concord, NH, received as a result of one proven rabid pet-store kitten in October 1994.
METHODS: All treatment recipients were interviewed by person or phone.
RESULTS: The median age of the treatment recipients was 14 years; 58% were female. The most common exposures were low risk (e.g., picking up, petting, nuzzling, or being scratched by a potentially rabid kitten). Local reactions to vaccine or immune globulin were reported by 76.5% of recipients, while 48.8% reported at least one systemic reaction. Cost for the biologicals was estimated at more than $1.1 million.
CONCLUSIONS: Because of the inadequacy of pet store records, the inconsistent application of treatment guidelines, and other factors, many people received postexposure treatment as a result of contacts that were unlikely to transmit rabies. The rates of local and systemic adverse reactions experienced were consistent with previous reports.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712277      PMCID: PMC1380629          DOI: 10.2105/ajph.86.8_pt_1.1149

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations.

Authors:  D B Fishbein; D W Dreesen; D F Holmes; R E Pacer; A B Ley; P A Yager; J W Sumner; F L Reid-Sanden; D W Sanderlin; T C Tong
Journal:  Vaccine       Date:  1989-10       Impact factor: 3.641

2.  Guillain-Barré syndrome and human diploid cell rabies vaccine.

Authors:  T Knittel; G Ramadori; W J Mayet; H Löhr; K H Meyer zum Büschenfelde
Journal:  Lancet       Date:  1989-06-10       Impact factor: 79.321

3.  A review of non-bite transmission of rabies virus infection.

Authors:  A Afshar
Journal:  Br Vet J       Date:  1979 Mar-Apr

4.  Neuroparalytic illness and human diploid cell rabies vaccine.

Authors:  K W Bernard; P W Smith; F J Kader; M J Moran
Journal:  JAMA       Date:  1982-12-17       Impact factor: 56.272

5.  Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine.

Authors:  E Bøe; H Nyland
Journal:  Scand J Infect Dis       Date:  1980

6.  Clinical experience with a human diploid cell rabies vaccine.

Authors:  L J Anderson; W G Winkler; B Hafkin; R A Keenlyside; L J D'Angelo; M W Deitch
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

7.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

8.  Postexposure trial of a human diploid cell strain rabies vaccine.

Authors:  L J Anderson; R K Sikes; C W Langkop; J M Mann; J S Smith; W G Winkler; M W Deitch
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

9.  Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination.

Authors:  L B Schonberger; E S Hurwitz; P Katona; R C Holman; D J Bregman
Journal:  Ann Neurol       Date:  1981       Impact factor: 10.422

  9 in total
  5 in total

1.  Rabies postexposure prophylaxis survey--Kentucky, 1994.

Authors:  M Auslander; C Kaelin
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

Review 2.  A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans.

Authors:  M I Meltzer; C E Rupprecht
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

3.  Postexposure treatment and animal rabies, Ontario, 1958-2000.

Authors:  Christopher P Nunan; Rowland R Tinline; Janet M Honig; David G A Ball; Peggy Hauschildt; Charles A LeBer
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

4.  Public health impact of reemergence of rabies, New York.

Authors:  Hwa-Gan H Chang; Millicent Eidson; Candace Noonan-Toly; Charles V Trimarchi; Robert Rudd; Barbara J Wallace; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

Review 5.  Healthy animals, healthy people: zoonosis risk from animal contact in pet shops, a systematic review of the literature.

Authors:  Kate D Halsby; Amanda L Walsh; Colin Campbell; Kirsty Hewitt; Dilys Morgan
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.